| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$385 |
Annual Report
|
27 Feb 2025 4:22PM |
$0.258 |
$0.190 |
fallen by
26.21%
|
|
| NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$33 |
Half-Year Results Announcement
|
27 Feb 2025 4:22PM |
$0.185 |
$0.195 |
risen by
5.41%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- NTAW reported a net loss of $42.8 million for 1H25.
- The loss includes a non-cash impairment charge of $39.2 million.
- Revenue decreased to $262.5 million from $264.3 million in 1H24.
- Gross profit margin fell to 28.9% from 31.2% in 1H24.
- Operating costs rose to 25.7% of revenue compared to 24.1% in 1H24.
- Net operating cash flow was negative $9.7 million.
- The company's net debt position increased to $64.2 million.
- Cost-cutting initiatives are being implemented to improve financial performance.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Powder Works Limited (MPW) ORDINARY FULLY PAID |
Industrials |
$8 |
Half Year Report to 31 December 2024
|
27 Feb 2025 4:21PM |
$0.075 |
$1.460 |
risen by
1,846.67%
|
|
MPW - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss after income tax reduced to $488,575 from $2,006,202.
- Revenue decreased slightly from $1,476,906 to $1,378,796.
- The company announced a binding agreement to acquire Metal Powder Works Inc.
- The name change to Metal Powder Works Limited was effective February 18, 2025.
- Net cash used in operating activities was $419,443.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$338 |
Appendix 3Y - Change of Director's Interest Notice x6
|
27 Feb 2025 4:19PM |
$1.150 |
$1.070 |
fallen by
6.96%
|
|
| NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$33 |
Appendix 4D & Half Year Financial Report
|
27 Feb 2025 4:19PM |
$0.185 |
$0.195 |
risen by
5.41%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for 1H25 was $262.47 million, a decrease of 0.7% from 1H24.
- NTAW reported a loss of $42.68 million compared to a profit of $0.89 million in the prior period.
- A non-cash impairment charge of $39.17 million was recorded against intangible assets.
- Net assets stood at $86.26 million, down from $117.30 million in June 2024.
- The company will cease distribution of Dunlop products effective July 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadence Capital Limited (CDM) ORDINARY FULLY PAID |
Financials |
$188 |
Appendix 4D Half Year Report 31 December 2024
|
27 Feb 2025 4:19PM |
$0.690 |
$0.630 |
fallen by
8.70%
|
|
CDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating loss before tax of $11,840,427 for the half-year ended 31 December 2024.
- Operating profit before tax for the previous year was $10,829,240.
- Gross performance of -3.6% compared to a 6.9% increase in the All Ordinaries Accumulation Index.
- Net investments valued at $186,308,227 as of December 2024.
- Net asset value of $288,228,284 as of December 2024.
- Interim dividend of 3.0 cents per share declared, partially franked at 50%, payable on 30 April 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$700 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:16PM |
$1.255 |
$1.200 |
fallen by
4.38%
|
|
PYC - Price-sensitive ASX Announcement
Full Release
Key Points
- PYC Therapeutics Limited is focused on precision medicines for genetic diseases.
- The company has four first-in-class drug candidates in development.
- Positive data from phase 1/2 studies for VP-001 for Retinitis Pigmentosa Type 11.
- Dosing has commenced for PYC-001 addressing Autosomal Dominant Optic Atrophy.
- Pre-clinical studies for PYC-003 targeting Polycystic Kidney Disease have been completed.
- A clinical candidate has been nominated for Phelan-McDermid Syndrome.
- The company reported a loss of $25.87 million for the half-year ending 31 December 2024.
- PYC aims to raise capital to support development through to 2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NTAW Holdings Limited (NTD) ORDINARY FULLY PAID |
Consumer Discretionary |
$33 |
Bank Facilities & Financial Covenants
|
27 Feb 2025 4:16PM |
$0.185 |
$0.195 |
risen by
5.41%
|
|
NTD - Price-sensitive ASX Announcement
Full Release
Key Points
- NTD entered into an amendment deed regarding finance facilities with the Commonwealth Bank of Australia.
- The Bank waived the Group's non-compliance with financial covenants.
- New financial covenant thresholds have been agreed upon.
- The trade finance facility limit was reduced from $93 million to $85.4 million.
- Further reduction of $12.4 million in the trade finance facility is scheduled by July 2025.
- These adjustments return the facility limit to levels prior to the Dunlop Distribution Agreements.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Benjamin Hornigold Limited (BHD) ORDINARY FULLY PAID |
Financials |
$4 |
Appendix 4D and Interim Report Dec 2024
|
27 Feb 2025 4:15PM |
$0.185 |
$0.175 |
fallen by
5.41%
|
|
BHD - Price-sensitive ASX Announcement
Full Release
Key Points
- Loss for the half-year increased to $464,805 from $321,616.
- Total revenue decreased due to realised and unrealised investment losses.
- Basic and diluted loss per share were both $1.92.
- Net tangible assets per ordinary security reduced to 26 cents.
- No dividends were paid, recommended, or declared during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ASF Group Limited (AFA) ORDINARY FULLY PAID |
Financials |
$2 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:13PM |
$0.005 |
$0.003 |
fallen by
40%
|
|
AFA - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 5% to $404,317.
- Consolidated loss after tax was $3,333,423.
- Losses were primarily due to shares of associates and investment impairments.
- Finance costs increased to $1,408,007.
- The Group has a cash balance of $1,670,913.
- Current liabilities exceed current assets by $5,953,948.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Investigator Resources Ltd (IVR) ORDINARY FULLY PAID |
Materials |
$41 |
Appendix 5B - Amended
|
27 Feb 2025 4:11PM |
$0.023 |
$0.026 |
risen by
13.04%
|
|
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$142 |
Half Year Accounts 31 December 2024
|
27 Feb 2025 4:11PM |
$0.285 |
$0.220 |
fallen by
22.81%
|
|
| Pureprofile Ltd (PPL) ORDINARY FULLY PAID |
Information Technology |
$47 |
Application for quotation of securities - PPL
|
27 Feb 2025 4:10PM |
$0.043 |
$0.040 |
fallen by
6.98%
|
|
| Traffic Technologies Ltd (TTI) ORDINARY FULLY PAID |
Industrials |
$4 |
Investor Presentation
|
27 Feb 2025 4:10PM |
$0.004 |
$0.003 |
fallen by
25%
|
|
TTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong order book with ongoing customer contracts
- Completed relocation of production and administration facilities
- Secured contracts for smart streetlights and tunnel lighting
- Achieved significant annualized cost savings in FY24 and FY25
- Positive outlook despite reduced operating revenue
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$385 |
Appendix 4E
|
27 Feb 2025 4:08PM |
$0.258 |
$0.190 |
fallen by
26.21%
|
|
BRN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue from continuing operations increased by 72% to $398,011.
- Operating loss decreased to $24,003,713 from $28,737,748.
- Loss for the period attributable to members improved by 15% to $24,431,185.
- No dividends declared for the year ended 31 December 2024.
- Net tangible assets per share increased to $0.96 from $0.83 in 2023.
- The financial report was audited by HLB Mann Judd with an unqualified opinion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Entertainment Rewards Ltd (EAT) ORDINARY FULLY PAID |
Communication Services |
$7 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:07PM |
$0.003 |
$0.005 |
risen by
66.67%
|
|
EAT - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 13% to $9.8 million.
- Net loss after tax was $5.66 million, up from $3.24 million the previous year.
- Operating EBITDA loss of $3.62 million compared to a loss of $1.77 million in the prior year.
- Membership sales increased by 13% on a cash basis, but decreased by 6% in the P&L due to timing differences.
- Seamless Rewards business showed strong growth with a 172% increase in success fees.
- Gift card sales rose by 27.6% with new offerings introduced.
- The company is focusing on revenue growth strategies and improving membership offerings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Camplify Holdings Limited (CHL) ORDINARY FULLY PAID |
Industrials |
$22 |
Camplify announces changes to its Chief Financial Officer
|
27 Feb 2025 4:07PM |
$0.570 |
$0.305 |
fallen by
46.49%
|
|
| Nutritional Growth Solutions Ltd (NGS) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Preliminary Final Report
|
27 Feb 2025 4:07PM |
$0.030 |
$0.023 |
fallen by
23.33%
|
|
NGS - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue decreased by 17% from the previous year.
- Reported loss of USD 2,544,000 for the year.
- No dividends proposed or declared.
- Successful capital raise of AUD 1.525 million via share placement.
- Closing cash balance at year-end was USD 31,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Traffic Technologies Ltd (TTI) ORDINARY FULLY PAID |
Industrials |
$4 |
Half Yearly Report and Accounts
|
27 Feb 2025 4:06PM |
$0.004 |
$0.003 |
fallen by
25%
|
|
TTI - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for the half year ended 31 December 2024 was A$9.9 million.
- Net loss for the period was A$6.7 million.
- Company's operations faced capital constraints impacting revenue.
- Strong demand for products due to government investment in infrastructure.
- Secured contract for LED streetlights with Sydney City Council.
- Transitioning to a SaaS model for recurring revenue.
- Restructuring operations to enhance efficiency and reduce costs.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$142 |
Appendix 4D 31 December 2024
|
27 Feb 2025 4:06PM |
$0.285 |
$0.220 |
fallen by
22.81%
|
|
EIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Announcement date is 27 February 2025
- Company is Echo IQ Limited
- Revenues from ordinary activities increased by 533.8% to $101,409
- Loss from ordinary activities after tax increased by 125.4% to $6,215,645
- Loss for the half-year also rose by 125.4% to $6,215,645
- No dividends paid, recommended, or declared during the current financial period
- Net tangible assets per ordinary security increased from 0.16 cents to 0.86 cents
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$8 |
$4.0m Non-Dilutionary Funding
|
27 Feb 2025 4:06PM |
$0.007 |
$0.004 |
fallen by
38.46%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Chimeric Therapeutics received A$4.0 million in non-dilutionary funding.
- Funding was provided by a US-based philanthropic family office.
- The funds are for the development of CHM CDH17 CAR-T therapy.
- CHM CDH17 targets CDH17, a marker associated with poor prognosis in gastrointestinal cancers.
- The therapy is in a Phase 1/2 clinical trial for advanced colorectal, gastric, and neuroendocrine cancers.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Oohmedia Limited (OML) ORDINARY FULLY PAID |
Communication Services |
$919 |
Becoming a substantial holder
|
27 Feb 2025 4:02PM |
$1.570 |
$1.705 |
risen by
8.60%
|
|
| RooLife Group Ltd (RLG) ORDINARY FULLY PAID |
Communication Services |
$8 |
Appendix 4D and Half Yearly Financial Statements
|
27 Feb 2025 3:57PM |
$0.004 |
$0.005 |
risen by
25%
|
|
RLG - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported revenue of $2,603,795 for the half-year ended 31 December 2024.
- Net loss of $949,742, slightly higher than the previous loss of $946,375.
- Focus on high-margin products to improve profitability.
- Strategic partnerships established in India for product distribution.
- Operational expenses reduced by 17% compared to the previous half-year.
- Company is enhancing its own brand portfolio including health and wellness products.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metal Hawk Limited (MHK) ORDINARY FULLY PAID |
Materials |
$56 |
Change in substantial holding
|
27 Feb 2025 3:56PM |
$0.333 |
$0.460 |
risen by
38.35%
|
|
| Pantoro Gold Limited (PNR) ORDINARY FULLY PAID |
Materials |
$1,222 |
Notice under section 708A(5)(e) of the Corporations Act 2001
|
27 Feb 2025 3:47PM |
$0.140 |
$3.110 |
risen by
2,121.43%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
